AU2001262177A1 - Method of treatment - Google Patents

Method of treatment

Info

Publication number: AU2001262177A1
Authority: AU; Australia
Prior art keywords: treatment
Prior art date: 2000-04-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2001262177A

Inventor

Joanne Bright

Nick Harrington

Naheed Mirza

Kelly Stanhope

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Ltd

Original Assignee

SmithKline Beecham Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-11

Filing date

2001-04-06

Publication date

2001-10-23

2001-04-06 Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd

2001-10-23 Publication of AU2001262177A1 publication Critical patent/AU2001262177A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AU2001262177A 2000-04-11 2001-04-06 Method of treatment Abandoned AU2001262177A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB0008921.9A GB0008921D0 (en)	2000-04-11	2000-04-11	Method of treatment
GB0008921		2000-04-11
PCT/EP2001/003926 WO2001076571A2 (en)	2000-04-11	2001-04-06	Use of sabcomeline in the treatment of anxiety

Publications (1)

Publication Number	Publication Date
AU2001262177A1 true AU2001262177A1 (en)	2001-10-23

Family

ID=9889701

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2001262177A Abandoned AU2001262177A1 (en)	2000-04-11	2001-04-06	Method of treatment

Country Status (6)

Country	Link
US (3)	US20030166703A1 (en)
EP (1)	EP1272182A2 (en)
JP (1)	JP2003530341A (en)
AU (1)	AU2001262177A1 (en)
GB (1)	GB0008921D0 (en)
WO (1)	WO2001076571A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0428170D0 (en) *	2004-12-23	2005-01-26	Biopartners Ltd	Mono and Combination Therapy
GB0428180D0 (en) *	2004-12-23	2005-01-26	Biopartners Ltd	Combination therapy
GT200600381A (en)	2005-08-25	2007-03-28		ORGANIC COMPOUNDS
JP2009506069A (en) *	2005-08-26	2009-02-12	ブレインセルス，インコーポレイティド	Neurogenesis through modulation of muscarinic receptors
GB0607949D0 (en) *	2006-04-21	2006-05-31	Minster Res The Ltd	Mono and combination therapy
GB0607952D0 (en) *	2006-04-21	2006-05-31	Minster Res Ltd	Novel treatment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9815383D0 (en) *	1998-07-15	1998-09-16	Smithkline Beecham Plc	Novel method of treatment

2000
- 2000-04-11 GB GBGB0008921.9A patent/GB0008921D0/en not_active Ceased
2001
- 2001-04-06 EP EP01936197A patent/EP1272182A2/en not_active Withdrawn
- 2001-04-06 US US10/257,175 patent/US20030166703A1/en not_active Abandoned
- 2001-04-06 WO PCT/EP2001/003926 patent/WO2001076571A2/en not_active Ceased
- 2001-04-06 JP JP2001574089A patent/JP2003530341A/en active Pending
- 2001-04-06 AU AU2001262177A patent/AU2001262177A1/en not_active Abandoned
2004
- 2004-01-08 US US10/753,890 patent/US20040147583A1/en not_active Abandoned
- 2004-11-01 US US10/978,854 patent/US20050085525A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1272182A2 (en)	2003-01-08
GB0008921D0 (en)	2000-05-31
US20040147583A1 (en)	2004-07-29
WO2001076571A2 (en)	2001-10-18
WO2001076571A3 (en)	2002-03-28
US20030166703A1 (en)	2003-09-04
JP2003530341A (en)	2003-10-14
US20050085525A1 (en)	2005-04-21

Publication	Publication Date	Title
AU2002215125A1 (en)	2002-05-27	Well treatment method
GB0014969D0 (en)	2000-08-09	Novel method of treatment
AU2001249881A1 (en)	2001-10-23	Method of treating the heart
AU2002257936A1 (en)	2002-12-03	Methods of well treatment
AU2002243231A1 (en)	2002-07-24	Method of treating autoimmune diseases
AU2001286983A1 (en)	2002-03-13	Method of treatment
AU2001240046A1 (en)	2001-09-17	Method of treating skin conditions
AU2001232263A1 (en)	2001-08-20	Method of treating seeds
AU2001294258A1 (en)	2002-04-29	Method of purifying plavastatin
AUPR731901A0 (en)	2001-09-20	Method of treatment
AU2001253836A1 (en)	2001-11-07	Method of treating cancer
AU2001262177A1 (en)	2001-10-23	Method of treatment
AU4598400A (en)	2000-12-12	Method of treatment
AU2001253560A1 (en)	2001-10-30	Methods of treatment
AU2382601A (en)	2001-07-09	Novel method of treatment
AUPQ662500A0 (en)	2000-05-04	Method of treatment
AUPQ949500A0 (en)	2000-09-07	Method of treatment
AUPR213000A0 (en)	2001-01-25	Method of treatment
HK1056502A (en)	2004-02-20	Methods of treatment
AU2002307061A1 (en)	2002-10-15	Method of treatment
AU2002257938A1 (en)	2002-12-03	Method of treatment
AU2002237631A1 (en)	2002-09-24	Method of treatment
AUPR542201A0 (en)	2001-06-28	Method of treatment
AUPR579801A0 (en)	2001-07-12	Method of treatment
AUPR750701A0 (en)	2001-09-27	Method of treatment